Attilio Orazi, M.D., FRCPath. (Engl.), Weill Cornell Medical College, New York, NY; Daniel A. Arber M.D., Stanford University School of Medicine, Stanford, CA
The 2008 revision of the World Health Organization (WHO) classification of hematopoietic tumors includes numerous changes to the classification of myeloid neoplasms. This course, given by two of the authors of the revised classification, will cover key diagnostic aspects of myeloid neoplasms, including acute myeloid leukemia, myelodysplastic syndromes, myeloproliferative neoplasms and the myelodysplastic/myeloproliferative overlap syndromes. An integrated diagnostic approach that includes assessment of morphologic features, immunophenotyping, cytogenetics and molecular genetics will be presented using a case-based and lecture format. This course is appropriate for practicing general pathologists, hematopathologists and pathology trainees.
Clinical histories with virtual slides of illustrative cases will be provided on the USCAP website prior to the meeting. While all of the myeloid disease entities will be described in the comprehensive course syllabus, the cases presented and lecture topics will vary each year to cover key elements of the 2008 WHO classification. All registrants will also receive a CD including the Power Point case presentations and the syllabus with a selected bibliography.
Upon completion of this course, participants should: 1) be familiar with the categories of myeloid disorders included in the 2008 WHO classification of hematopoietic tumors; 2) understand the basics of the molecular genetics of myeloid proliferations, also in the light of advances in targeted molecular therapies; 3) know the value of ancillary techniques in the diagnosis of myeloid neoplasms and how these should be integrated with morphology within the classificative framework.
(New Course) This course may be used for CME credits or SAM's credits.